Category: Biotech

Custom Lucite commemorating the private placement of shares issued by Cellectar. Madison, Wisconsin-based Cellectar focuses on developing cancer drugs and imaging tools.

Lucite tombstone commemorating a follow-on offering by WaferGen Biosystems. The Fremont, California-based company develops systems for genome analysis for use in the life science and pharmaceutical industries.

Financial tombstone commemorating two offerings of stock in Neurotrope BioScience. Headquartered in Newark, New Jersey, Neurotrope is a biopharmaceutical and diagnostics firm principally focused on the diagnosis and treatment of Alzheimer’s Disease.

Corporate tombstone commemorating financing provided for Providence-based Nabsys. The life sciences and healthcare company focuses on applications for DNA sequencing research.

Custom Lucite celebrating the IPO of Enzymotec, the Israeli developer of bio-functional, lipid-based compounds for medical and nutritional applications.

Lucite tombstone marking the private placement of shares of DARA Biosciences. DARA is a specialty pharmaceutical company headquartered in Raleigh, North Carolina.

Lucite tombstone marking an acquisition by Oxygen Biotherapeutics, now known as Tenax Therapeutics.

Custom Biotech Corporate Tombstone recognizing the merger of Antitope and PolyTherics. Antitope was advised by London-based Ferghana Partners Group.

Financial tombstone marking the initial public offering of stock by Cambridge, Massachusetts-based biotech firm Bluebird. The company focuses on gene therapies addressing both genetic and orphan diseases.